Beneficial effects of luseogliflozin for hepatic steatosis and fibrosis indexes with a reduction of body weight and an increase in serum albumin levels in patients with diabetes: a pooled meta- analysis of phase i i i clinical trials using inverse probability treatment weighting propensity analysis